Adam Christie
Gründer bei Calcivis Ltd.
Profil
Adam Christie is the founder and the Chief Executive Officer & Director of Calcivis Ltd., a company founded in 2012.
He is currently a Non-Executive Director at MGB Biopharma Ltd.
Mr. Christie was also the Executive Chairman of LUX Assure Ltd.
from 2010 to 2011.
He held the position of Director-Business Development at PPL Therapeutics Plc.
Mr. Christie worked as a Principal at Bayer Schering Pharma AG and as the Head-Marketing at GSK Plc.
He was also a Principal at Fisons Plc and a Pharmaceutical Equity Analyst at ABN AMRO Hoare Govett.
From 2004 to 2008, Mr. Christie served as the Chief Business Officer at PowderMed Ltd.
Mr. Christie completed his undergraduate degree at The University of Southampton and holds an MBA from the University of Warwick.
Aktive Positionen von Adam Christie
| Unternehmen | Position | Beginn |
|---|---|---|
MGB Biopharma Ltd.
 MGB Biopharma Ltd. BiotechnologyHealth Technology MGB Biopharma Ltd. develops anti-infective medicines. Its lead candidate, MGB-BP-3, is an antibacterial which is active against important multi-resistant and susceptible Gram-positive pathogens. The firm develops an oral formulation of MGB-BP-3 for the treatment of clostridium difficile associated disease. The company was founded by Miroslav Ravic, Gavin David Clark and Raymond Spencer in 2010 and is headquartered in Glasgow, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Calcivis Ltd.
 Calcivis Ltd. Medical DistributorsDistribution Services Calcivis Ltd. provides dental assessment services. The firm offers preventive dentistry, CALCIVIS photoprotein, and CALCIVIS imaging devices. The company was founded by Adam Christie and Bruce Vernon in 2012 and is headquartered in Edinburgh, the United Kingdom. | Gründer | 01.01.2012 |
Ehemalige bekannte Positionen von Adam Christie
| Unternehmen | Position | Ende |
|---|---|---|
PowderMed Ltd.
 PowderMed Ltd. Pharmaceuticals: MajorHealth Technology PowderMed Ltd. develops immunotherapeutic products. It focuses on the clinical development and manufacture of therapeutic and prophylactic DNA-based vaccines for viral diseases and cancer. The company has 4 clinical and 3 pre-clinical stage projects. The company was founded February 25, 2004 by Dr. Clive Dix & Dr. Beadle and is headquartered at Oxford, The United Kingdom. | Corporate Officer/Principal | 15.05.2008 |
| ABN AMRO Hoare Govett | Corporate Officer/Principal | - |
| GSK PLC | Vertrieb & Marketing | - |
PPL Therapeutics Plc
 PPL Therapeutics Plc Pharmaceuticals: MajorHealth Technology PPL Therapeutics Plc produces commercially valuable proteins. It is a multinational corporation operating in the field of recombinant proteins using transgenic technology. The company does business in the pharmaceutical, biotechnology and nutraceutical industries. PPL is headquartered in Edinburgh, UK. | Corporate Officer/Principal | - |
Fisons Plc
 Fisons Plc Pharmaceuticals: OtherHealth Technology Fisons Plc Manufactured and supplied ethical and proprietary medicines, veterinary products, laboratory and educational scientific equipment, clinical diagnostic supplies and garden products. The company was headquartered in Ipswichm the United Kingdom. | Corporate Officer/Principal | - |
Ausbildung von Adam Christie
| The University of Southampton | Undergraduate Degree |
| University of Warwick | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GSK PLC | Health Technology |
| Private Unternehmen | 8 |
|---|---|
| Bayer Schering Pharma AG | Health Technology |
Calcivis Ltd.
Calcivis Ltd. Medical DistributorsDistribution Services Calcivis Ltd. provides dental assessment services. The firm offers preventive dentistry, CALCIVIS photoprotein, and CALCIVIS imaging devices. The company was founded by Adam Christie and Bruce Vernon in 2012 and is headquartered in Edinburgh, the United Kingdom. | Distribution Services |
PPL Therapeutics Plc
PPL Therapeutics Plc Pharmaceuticals: MajorHealth Technology PPL Therapeutics Plc produces commercially valuable proteins. It is a multinational corporation operating in the field of recombinant proteins using transgenic technology. The company does business in the pharmaceutical, biotechnology and nutraceutical industries. PPL is headquartered in Edinburgh, UK. | Health Technology |
Fisons Plc
Fisons Plc Pharmaceuticals: OtherHealth Technology Fisons Plc Manufactured and supplied ethical and proprietary medicines, veterinary products, laboratory and educational scientific equipment, clinical diagnostic supplies and garden products. The company was headquartered in Ipswichm the United Kingdom. | Health Technology |
| ABN AMRO Hoare Govett | Finance |
PowderMed Ltd.
PowderMed Ltd. Pharmaceuticals: MajorHealth Technology PowderMed Ltd. develops immunotherapeutic products. It focuses on the clinical development and manufacture of therapeutic and prophylactic DNA-based vaccines for viral diseases and cancer. The company has 4 clinical and 3 pre-clinical stage projects. The company was founded February 25, 2004 by Dr. Clive Dix & Dr. Beadle and is headquartered at Oxford, The United Kingdom. | Health Technology |
LUX Assure Ltd.
 LUX Assure Ltd. Chemicals: Major DiversifiedProcess Industries LUX Assure Ltd. provides technology solutions to monitor difficult-to-detect chemicals used by the oil industry. Its offers CoMic a technology that enables optimization of chemicals used for corrosion protection and OMMICA a testing kit for analyzing the concentration of the thermodynamic hydrate inhibitors methanol and monoethylene glycol in water, crude oil, and condensate. The company was founded by Patrick Hickey on May 30, 2001 and is headquartered in Edinburgh, the United Kingdom. | Process Industries |
MGB Biopharma Ltd.
MGB Biopharma Ltd. BiotechnologyHealth Technology MGB Biopharma Ltd. develops anti-infective medicines. Its lead candidate, MGB-BP-3, is an antibacterial which is active against important multi-resistant and susceptible Gram-positive pathogens. The firm develops an oral formulation of MGB-BP-3 for the treatment of clostridium difficile associated disease. The company was founded by Miroslav Ravic, Gavin David Clark and Raymond Spencer in 2010 and is headquartered in Glasgow, the United Kingdom. | Health Technology |
